RWA
Redhawk Wealth Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.35M | Buy |
5,268
+584
| +12% | +$260K | 0.29% | 80 |
|
|
2025
Q1 | $2.27M | Sell |
4,684
-655
| -12% | -$318K | 0.31% | 67 |
|
|
2024
Q4 | $2.15M | Buy |
5,339
+153
| +3% | +$61.6K | 0.29% | 71 |
|
|
2024
Q3 | $2.41M | Sell |
5,186
-13
| -0.3% | -$6.05K | 0.34% | 70 |
|
|
2024
Q2 | $2.44M | Sell |
5,199
-1,071
| -17% | -$502K | 0.37% | 65 |
|
|
2024
Q1 | $2.62M | Sell |
6,270
-6
| -0.1% | -$2.51K | 0.43% | 52 |
|
|
2023
Q4 | $2.55M | Buy |
6,276
+646
| +11% | +$263K | 0.5% | 49 |
|
|
2023
Q3 | $1.96M | Buy |
5,630
+157
| +3% | +$54.6K | 0.65% | 37 |
|
|
2023
Q2 | $1.93M | Buy |
5,473
+900
| +20% | +$317K | 0.59% | 35 |
|
|
2023
Q1 | $1.44M | Buy |
4,573
+147
| +3% | +$46.3K | 0.48% | 49 |
|
|
2022
Q4 | $1.28M | Buy |
4,426
+205
| +5% | +$59.2K | 0.5% | 52 |
|
|
2022
Q3 | $1.22M | Buy |
+4,221
| New | +$1.22M | 0.52% | 41 |
|
|
2020
Q4 | – | Sell |
-1,560
| Closed | -$425K | – | 255 |
|
|
2020
Q3 | $425K | Buy |
1,560
+64
| +4% | +$17.4K | 0.12% | 137 |
|
|
2020
Q2 | $434K | Sell |
1,496
-87
| -5% | -$25.2K | 0.15% | 109 |
|
|
2020
Q1 | $377K | Buy |
+1,583
| New | +$377K | 0.17% | 98 |
|